YB new stock pitches (Mon, Jun 1)

Gibraltar Industries (ROCK), a Buffalo, New York-based aluminum metal roofing manufacturer (80% residential), trades at $39.50 with a price target of $100 by mid-2028 (~2.5x). Metal roofs last 40-100 years versus 15-30 for asphalt shingles but cost ~40% more, making them attractive to homeowners near retirement; Gibraltar also sells aluminum for greenhouses and solar panel structures. The stock is down partly due to the February 2026 debt-funded acquisition of OmniMax International (gutters/drainage leader) for $1.335 billion at 12x EBITDA (8.5x post-synergies), which raised leverage to 3.9x debt/EBITDA with five- and seven-year notes at SOFR+2.25% and no shareholder dilution; management plans to direct all cash flow toward debt repayment to reach 2.5x or below within two years. Full-year combined guidance is over $310 million EBITDA on $1.76 billion sales, implying 3.7x P/EBITDA and 0.66x P/sales versus a historical 1.5x P/sales (which would imply ~$90, with cyclicality and growth pushing past $100). Trailing twelve-month net income appears negative due to non-cash mark-to-market acquisition accounting, with SG&A savings expected ahead. Bullish signals include CFO and General Counsel insider buys near $35, plus tailwinds from anticipated Fed rate cuts (overnight rate likely cut 2-6 times as the overnight/10-year spread of ~0.9% normalizes toward historical 1.5-2.5%), cross-selling, and potential solar/data-center upside. Key risk is aluminum prices and interest-rate sensitivity, so the author pairs ROCK with a hedging long position in Cleveland Cliffs (CLF), an undervalued steel name correlated to aluminum.

Read the full article here. Read time: 5 min

Serviceware SE ($SJJ.DE), an AI-native enterprise service management (ESM) provider and German microcap, presents a compelling multi-horizon opportunity trading at just 0.5x EV/Sales with cash (~€36.7M) equal to roughly 33% of its market cap. The historically strong correlation between Serviceware and ServiceNow ($NOW) recently broke down, with $NOW outperforming by nearly +23%—notable given Serviceware's lower liquidity should make it more sensitive to SaaS sentiment swings. The bull case rests on accelerating fundamentals: Q1 backlog rose +18% in contract assets, seven-figure SaaS deals signed in Q1 are expected to hit the balance sheet and Q2 results in July (with the author forecasting >30% SaaS growth), and operating leverage is improving via the company's own AI tools, with OPEX flat against a ~30% SaaS CAGR. The business is profitable, with management guiding for strong EBIT and EBITDA growth. Additional support comes from Serviceware's first-ever €5M share buyback launching June 1, which can absorb any post-selloff overhang. Quirin Privatbank raised its price target from €30 to €33 (+203%) on May 11. The author argues most downside is already priced in, and that a re-rating to merely ~2x EV/Sales (calculated as €150M sales x2 + €36.7M net cash ÷ 10.5M shares = €32) would yield 3x upside under conservative assumptions, with the buyback supporting reversion to the mean.

Read the full article here. Read time: 2 min

Bruker Corporation ($BRKR) is a high-end physics and chemistry lab equipment maker that I've initiated a new position in, with plans to add along the way, based on a thesis similar to my $VECO play: the complexity of advanced packaging and next-gen HBM now demands new manufacturing tools as the industry pivots from 2D transistor shrinking (Moore's Law) to vertical 3D stacking due to physical limits. Bruker realized the same physics used to inspect molecules can inspect silicon wafers, and made strategic acquisitions of niche market leaders just as advanced packaging emerged—including buying Veeco's Atomic Force Microscopy (AFM) business in 2010 for $229.4 million in cash. The company now operates as a 'toll booth' embedded at multiple phases of the advanced packaging process via four core tools: X-Ray Metrology (verifies hidden wiring and bumps inside the chip sandwich), AFM (uses an atoms-wide needle to ensure wafer flatness), White Light Interferometry (a 3D optical camera scanning microscopic bumps and drill holes for defects), and Nanomechanical Metrology (pokes layers with a diamond tip to test bond strength). These tools are embedded in cleanroom blueprints of giants like $TSM, $MU, SK Hynix, Samsung, and $INTC as they build out billions in new advanced packaging plants. The alpha lies in the fact that the semiconductor segment is only 10% of sales yet growing 20% YoY and expected to accelerate, while the core lifesciences business (90% of sales) is in a deep trough dragged down by temporary U.S. academic funding freezes and a soft China market—creating hidden optionality. Management is aggressively cutting corporate costs while leaning into the high-margin, hardware-critical AI segment; revenue hasn't hit the books yet, but the key leading indicator—book-to-bill ratio above 1.0x for the third consecutive quarter—proves demand is outpacing supply. Technicals also look strong, with a double bottom forming after a major capitulation, a bounce on a major uptrend, and moving averages starting to curl up; I'd look for dips to get positioned.

Read the full article here. Read time: 3 min